NANOGEN INC

Research NANOGEN INC (NGEN) on Bullrun: market cap USD 208.16M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNGEN
• ExchangeNASDAQ
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 208.16M
• Financial periodQ1 2026
• Net income-USD 1.68M

Valuation Snapshot

latest market cap is USD 208.16M.

About NANOGEN INC

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease;

Frequently asked questions

What is NANOGEN INC's market cap?

NANOGEN INC's market capitalization is USD 208.16M.

What does NANOGEN INC do?

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.